Knowledge Center

November 2017 Scorecard

The November 2017 scorecard for the signals generated from Sonal can be downloaded here. The results are summarized in this table: Scorecard Total Repurchases M&A Guidance Contracts Clinical Trials Correct – Prev Close to Next Close 65% 65% 89% 63% 57% 67% Correct – Prev Close to Next Session Peak 87% 86% 89% 83% 95% […]

Read more...

Catalyst Pharmaceuticals Announces Positive Phase 3 Clinical Trial Results

On November 27, Catalyst Pharmaceutical, Inc. (CPRX) announced positive phase 3 clinical trial results from its drug Firdapse. This was the second phase 3 trial of Firdapse, which shows statistically significant improvement for symptomatic treatment of Lambert-Eaton Myasthenic Syndrome (LEMS). LEMS is a rare autoimmune disorder in which nerves have trouble sending to muscle cells, […]

Read more...

Lannett Announces FDA Acceptance of New Drug Application

On December 1, Lannett Company, Inc. (LCI) announced FDA acceptance of its 505(b)(2) New Drug Application (NDA) for Cocaine Hydrochloride (HCl) Topical Solution. The drug is a proprietary local topical anesthetic with the proposed name Numbrino. The submission is supported by two successful Phase 3 clinical trials.   Sonal detected the event and sent an […]

Read more...

Fusion Telecommunications Receives Two New Contract Awards

On November 30, Fusion Telecommunications (FSNN) announced that the company received two new contracts totaling $1.6 million. Fusion will use its advanced cloud voice and connectivity solutions to improve communications systems for a healthcare company as well as to a hospitality company. These new contracts mark the growth of Fusion’s services across the country in […]

Read more...

Emergent Biosolutions Receives FDA Approval for Vaccine Production

On November 20, Emergent Biosolutions Inc. (EBS) announced that the company received FDA approval on its supplemental Biologics License Application (sBLA) for the production of the ACAM2000 vaccine. This live vaccine for smallpox will be manufactured in the company’s new live viral manufacturing facility in Canton, Massachusetts. It is the only vaccine approved by the […]

Read more...

Nanometrics Approves $50 Million Share Buyback

On November 15, Nanometrics Incorporated (NANO) announced that its Board of Directors approved a $50 million share repurchase program. Nanometrics is a leading provider of advanced control systems.   Sonal detected an event and sent an alert to subscribers at 9:00 am. The next trade took place when the market opened for regular trading at […]

Read more...

JA Solar Enters Agreement to Go Private

On November 17, JA Solar Holdings Co., Ltd. (JASO) announced that the company entered into an agreement to go private. An investor group plans to purchase the company in an all-cash transaction valuing the company at $362.1 million. At the agreement’s effective time, all current shares of JASO will no longer exist. Shareholders will have […]

Read more...

Magal Awarded $3.5 Million Airport Security Contract

Magal Security Systems, Ltd. (MAGS) announced on November 10 that the company was awarded new contract to provide integrated security solutions at some of the world’s biggest airports. The contract totals around $3.5 million and includes international sites such as Barcelona airport and Indira Gandhi International airport in New Delhi. Magal is a leading international […]

Read more...